Solid Tumour News Today

Study highlights opportunity for treatment intensification in this population since approximately 50 percent of patients with high-risk localised prostate...

Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development - News - PharmaTimes

New Delhi [India], October 21 (ANI/SRV): Surat Hematology Centre, one of the leading Hematology centres in Surat, recently celebrated a landmark achievement of the 50th successful Bone Marrow Transplant. The Centre specialises in Bone Marrow Transplants and the treatment of blood disorders in the South Gujarat region and has some of the best Hematologists in Surat as their founders. The centre has achieved this remarkable feat in a very short period of time. The centre was established by two vis...

QBiotics Group Limited (QBiotics), a life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals, is pleased to announce that it has dosed the first patient in the Phase Ib/IIa clinical trial of the company's lead oncology molecule, tigilanol tiglate in combination with MSD's immune checkpoint inhibitor KEYTRUDA® (pembrolizumab) for patients with unresectable melanoma, the deadliest form of skin cancer.

AVA6000 is pro-drug form of the chemotherapy doxorubicin, modified using Avactas pre|CISION chemistry - News - PharmaTimes